Additional file 1 of Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group

Authors :: Hirata, Kenro
Hamamoto, Yasuo
Ando, Masahiko
Imamura, Chiyo K.
Yoshimura, Kenichi
Yamazaki, Kentaro
Hironaka, Shuichi
Muro, Kei
Publication Year :: 2020
Publisher :: figshare, 2020.
Abstract: Additional file 1. SPIRIT 2013 Checklist.

Full Text Access

Tools